|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,513.25 INR | +0.76% |
|
+2.37% | +1.71% |
EPS & Dividend: GlaxoSmithKline Pharmaceuticals Limited
| Fiscal Period: March | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
| Dividend per Share 2 | 30 | 32 | 32 | 42 | 57 | 29.5 | 29.5 |
| Rate of return | 1.8% | 2.42% | 1.65% | 1.46% | 2.5% | 1.18% | 1.18% |
| EPS 2 | 100 | 36.05 | 34.83 | 54.76 | 61.15 | 67.9 | 76.48 |
| Distribution rate | 30% | 88.8% | 91.9% | 76.7% | 93.2% | 43.4% | 38.6% |
| Reference price 2 | 1,662.95 | 1,324.15 | 1,943.10 | 2,877.30 | 2,283.40 | 2,494.20 | 2,494.20 |
| Nbr of stocks (in thousands) | 1,69,406 | 1,69,406 | 1,69,406 | 1,69,406 | 1,69,406 | 1,69,406 | - |
| Announcement Date | 16/05/22 | 17/05/23 | 17/05/24 | 13/05/25 | 13/05/26 | - | - |
1INR in Million2INR
Estimates
Past dividends: GlaxoSmithKline Pharmaceuticals Limited
| 29/05/2026 | Ex-dividend date - 57 INR | 09:30 am |
Upcoming Events: GlaxoSmithKline Pharmaceuticals Limited
| 03/08/2026 | Présentation aux Actionnaires / Analystes | Day | |
| 03/08/2026 | Board of Directors Meeting | Day | |
| 03/08/2026 | Earnings release | Q1 2027 |
| Dividend Yield (N) | Dividend Yield (N+1) | P/E (N) | Price to Book (N) | EV / Sales (N) | ||
|---|---|---|---|---|---|---|
 | 1.18% | 1.18% | 36.73x | 16.09x | - | |
| 0.57% | 0.63% | 35.39x | 21.51x | 12.58x | |
| 2.07% | 2.17% | 27.79x | 7.06x | 6.35x | |
| 2.68% | 2.81% | 33.47x | 12788.45x | 7.59x | |
| 2.86% | 2.93% | 20.98x | 7.46x | 4.63x | |
| 2.82% | 2.94% | 21.62x | 6.25x | 5.7x | |
| 1.98% | 2.09% | 21.08x | 4.94x | 4.45x | |
| 3.54% | 3.46% | 14.13x | 6.24x | 5.26x | |
| 2.71% | 2.87% | 24.37x | 18.74x | 6.41x | |
| 2.52% | 2.6% | -47.14x | 8.26x | 5.65x | |
| Average | 2.29% | 2.37% | 18.84x | 1,288.50x | 6.51x | |
| Weighted average by Cap. | 1.98% | 2.06% | 24.73x | 1,615.21x | 7.88x |
Year-on-year evolution of the Yield
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Estimates Revisions
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Annual Profit -
Select your edition
All financial news and data tailored to specific country editions
